World's Best Scientists 2026 revealed!
Philippe Mathurin

Philippe Mathurin

D-Index & Metrics

Medicine

D-Index
101
Citations
46656
World Ranking
7860
National Ranking
239

Overview

Philippe Mathurin is a researcher affiliated with the University of Lille in France. Their work primarily focuses on the field of Medicine, specifically within subfields such as Epidemiology, Hepatology, Pathology and Forensic Medicine, Surgery, and Endocrinology, Diabetes and Metabolism. The scientist's research covers several topics including Liver Disease Diagnosis and Treatment, Alcohol Consumption and Health Effects, Liver Disease and Transplantation, Hepatitis C virus research, Hepatocellular Carcinoma Treatment and Prognosis, Hepatitis B Virus Studies, and Diet, Metabolism, and Disease.

Their publication record includes a number of articles in well-recognized journals with a significant concentration in hepatology-related venues. Frequent publication outlets include:

  • Journal of Hepatology
  • Hepatology
  • JHEP Reports
  • Liver International
  • UNC Libraries

Recent significant papers authored or co-authored by Philippe Mathurin include:

  • Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis, 2020, Gastroenterology
  • Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors, 2022, Nature Reviews Gastroenterology & Hepatology
  • Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials, 2020, Journal of Hepatology
  • Diagnosis and Treatment of Alcohol-Associated Liver Disease, 2021, JAMA
  • Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta, 2020, Journal of Hepatology

The scientist collaborates frequently with a set of co-authors, with the highest number of joint publications involving:

  • Alexandre Louvet
  • Guillaume Lassailly
  • Sébastien Dharancy
  • Victor de Lédinghen
  • Fabien Zoulim

Best Publications

  • Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa

  • Early Liver Transplantation for Severe Alcoholic Hepatitis

    Philippe Mathurin;Christophe Moreno;Didier Samuel;Jérôme Dumortier

  • Meta‐analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

    T Poynard;V Leroy;M Cohard;T Thevenot

  • Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease

    Yi Duan;Yi Duan;Cristina Llorente;Cristina Llorente;Sonja Lang;Katharina Brandl

  • EASL Clinical Practice Guidelines: Management of alcohol-related liver disease

    Mark Thursz;Antoni Gual;Caroline Lackner;Philippe Mathurin

  • Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients

    Guillaume Lassailly;Robert Caiazzo;David Buob;Marie Pigeyre

  • Impact of hepatitis B and C virus on kidney transplantation outcome

    Philippe Mathurin;Catherine Mouquet;Thierry Poynard;Cheickna Sylla

  • CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)

    T. Yau;J.W. Park;R.S. Finn;A.-L. Cheng

  • A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.

    T Poynard;P Bedossa;M Chevallier;P Mathurin

  • Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study

    Josep M. Llovet;Thomas Decaens;Jean-Luc Raoul;Eveline Boucher

  • Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial

    Rafael Bañares;Rafael Bañares;Frederik Nevens;Fin Stolze Larsen;Rajiv Jalan

  • Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

    Fabrice Carrat;Hélène Fontaine;Céline Dorival;Mélanie Simony

  • A comparison of fibrosis progression in chronic liver diseases

    Thierry Poynard;Philippe Mathurin;Ching-Lung Lai;Dominique Guyader

  • A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.

    Christophe Corpechot;Olivier Chazouillères;Alexandra Rousseau;Antonia Le Gruyer

  • Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

    Pierre Nahon;Pierre Nahon;Valérie Bourcier;Richard Layese;Etienne Audureau

  • Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease

    Philippe Mathurin;Antoine Hollebecque;Laurent Arnalsteen;David Buob

  • A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.

    Sylvie Naveau;Sylvie Chollet-Martin;Sébastien Dharancy;Philippe Mathurin

  • Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data

    Philippe Mathurin;John O'Grady;Robert L. Carithers;Martin Phillips

  • A randomized trial of prednisolone in patients with severe alcoholic hepatitis.

    Marie-José Ramond;Thierry Poynard;Bernard Rueff;Philippe Mathurin

  • Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia

    David W. Crabb;Ramon Bataller;Naga P. Chalasani;Patrick S. Kamath

Frequent Co-Authors

Victor de Ledinghen
Victor de Ledinghen Grenoble Alpes University
Jean-Pierre Bronowicki
Jean-Pierre Bronowicki University Hospital of Nancy
Dominique Larrey
Dominique Larrey University of Montpellier
Albert Tran
Albert Tran Inserm : Institut national de la santé et de la recherche médicale
Stanislas Pol
Stanislas Pol Université Paris Cité
Marc Bourlière
Marc Bourlière Hôpital Saint Joseph
Thierry Poynard
Thierry Poynard Sorbonne University
Paul Calès
Paul Calès University of Angers
Laurent Alric
Laurent Alric Federal University of Toulouse Midi-Pyrénées

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering studying Medicine in the USA, exploring related online degrees can open up diverse career opportunities in healthcare. For those interested in leadership roles, earning a bachelors in healthcare administration provides an affordable entry point into healthcare management and operations.

Advancing further, the cheapest mha programs offer flexible options to develop advanced leadership skills essential for higher-level administrative positions in hospitals, clinics, and public health organizations.

Clinical careers also benefit from affordable online pathways. The cheapest dnp programs are designed for nurses aiming for the highest level of clinical practice, while online pharmacy schools allow students to earn a doctorate in pharmacy remotely and conveniently.

Each of these accredited online programs can help shape a rewarding career in healthcare, offering both flexibility and cost-effectiveness for students in the US and beyond.

Best Scientists Citing Philippe Mathurin

Trending Scientists

Recently Published Articles